Medtronic invests in stroke device firm Mindguard
This article was originally published in Clinica
Medtronic has obtained European distribution rights to an implantable system designed to prevent ischaemic stroke. As part of the deal, the Minneapolis, Minnesota firm participated in a $15m financing for the device's developer, Mindguard, of Caesarea, Israel. The precise sum invested by Medtronic was not revealed, but Mindguard chief financial officer Elad Naggar said it amounted to "several million dollars".